ES547810A0 - Procedimiento para la preparacion de derivados de pirazol - Google Patents

Procedimiento para la preparacion de derivados de pirazol

Info

Publication number
ES547810A0
ES547810A0 ES547810A ES547810A ES547810A0 ES 547810 A0 ES547810 A0 ES 547810A0 ES 547810 A ES547810 A ES 547810A ES 547810 A ES547810 A ES 547810A ES 547810 A0 ES547810 A0 ES 547810A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
pyrazole derivatives
pyrazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547810A
Other languages
English (en)
Other versions
ES8608491A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heumann Ludwig and Co GmbH
Original Assignee
Heumann Ludwig and Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig and Co GmbH filed Critical Heumann Ludwig and Co GmbH
Publication of ES8608491A1 publication Critical patent/ES8608491A1/es
Publication of ES547810A0 publication Critical patent/ES547810A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES547810A 1984-10-17 1985-10-11 Procedimiento para la preparacion de derivados de pirazol Expired ES8608491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438027 DE3438027A1 (de) 1984-10-17 1984-10-17 Pyrazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8608491A1 ES8608491A1 (es) 1986-07-16
ES547810A0 true ES547810A0 (es) 1986-07-16

Family

ID=6248096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547810A Expired ES8608491A1 (es) 1984-10-17 1985-10-11 Procedimiento para la preparacion de derivados de pirazol

Country Status (8)

Country Link
EP (1) EP0181471A1 (es)
JP (1) JPS6197266A (es)
DE (1) DE3438027A1 (es)
DK (1) DK468985A (es)
ES (1) ES8608491A1 (es)
GR (1) GR852483B (es)
IL (1) IL76603A0 (es)
NZ (1) NZ213806A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
DK468985A (da) 1986-04-18
ES8608491A1 (es) 1986-07-16
DE3438027A1 (de) 1986-04-17
IL76603A0 (en) 1986-02-28
JPS6197266A (ja) 1986-05-15
GR852483B (es) 1986-02-26
DK468985D0 (da) 1985-10-14
NZ213806A (en) 1988-05-30
EP0181471A1 (de) 1986-05-21

Similar Documents

Publication Publication Date Title
ES540048A0 (es) Procedimiento para la fabricacion de derivados de azolil ci-cloalcanol
ES546484A0 (es) Procedimiento para la preparacion de derivados de furazano
ES548798A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo
ES544286A0 (es) Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos
AR231637A1 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina
ES557428A0 (es) Procedimiento para la fabricacion de derivados nucleosidos
ES547924A0 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
AR231537A1 (es) Procedimiento para la preparacion de derivados de la piridazina
MX159669A (es) Procedimiento para la preparacion de derivados de acilamida
MX162421A (es) Procedimiento para la preparacion de n-acilfenilalaninas
ES506687A0 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
MX156087A (es) Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas
ES541906A0 (es) Procedimiento para la preparacion de glicidiloxidicetonas
ES533497A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol
ES549677A0 (es) Procedimiento para la preparacion de derivados de acidos 1- fenil-imidazol-5-carboxilicos
MX157777A (es) Procedimiento para la preparacion de derivados de ascoclorina
ES542071A0 (es) Procedimiento para la preparacion de ergolinas
ES548651A0 (es) Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
ES546908A0 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES540943A0 (es) Procedimiento para la preparacion de derivados diaminicos
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES531159A0 (es) Procedimiento para la preparacion de aminociclotiadiazinas
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
AR242387A1 (es) Procedimiento para la preparacion de nuevos derivados de apovincaminol
MX7420E (es) Procedimiento para la preparacion de carbamoil-lactama-n-substituida